OTC & Nutraceuticals Australia

Australia Insulin Resistance Supplements Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Insulin Resistance Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $23.1 Mn Placeholder estimate
Estimate 2025 $25.6 Mn 1.3% of the global market
Projected 2034 $63.3 Mn 147.6% Adds $37.7 Mn over 9 forecast years
CAGR 2025–2034 10.6% Faster than 83% of 82 OTC & Nutraceuticals markets here
Key players 5
  • Australia is 1.34% of the global market.
  • In APAC, the largest is China at $178.7 Mn.
  • Fastest growing: India at 12.2% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$37.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insulin Resistance Supplements Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $23.1 Mn — —
2025 (base) $25.6 Mn +$2.5 Mn —
2026 (forecast) $28.3 Mn +$2.7 Mn +10.6%
2027 (forecast) $31.3 Mn +$3.0 Mn +22.3%
2028 (forecast) $34.6 Mn +$3.3 Mn +35.3%
2029 (forecast) $38.3 Mn +$3.7 Mn +49.6%
2030 (forecast) $42.3 Mn +$4.1 Mn +65.5%
2031 (forecast) $46.8 Mn +$4.5 Mn +83%
2032 (forecast) $51.8 Mn +$5.0 Mn +102.4%
2033 (forecast) $57.2 Mn +$5.5 Mn +123.9%
2034 (forecast) $63.3 Mn +$6.1 Mn +147.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Insulin Resistance Supplements Market Analysis at a glance
Market size, 2025$25.6 Mn placeholder estimate
Forecast, 2034$63.3 Mn placeholder estimate
Growth (CAGR), 2025–203410.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsIngredient, form and distribution channel (see all)
Key playersThorne, NOW Foods, Nature’s Bounty, Pure Encapsulations, LLC, Wholesome Story (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
Active clinical trials1 in AustraliaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Insulin Resistance Supplements Market Analysis Executive Summary

Insulin resistance supplements contain ingredients such as berberine, inositol, chromium and cinnamon that claim to support healthy blood sugar.

Key segments of the insulin Resistance Supplements market include ingredient (Berberine, Inositol and Chromium) and form (Capsules, Powders and Gummies).

Bar chart: Australia Insulin Resistance Supplements market size, 2024–2034, placeholder estimates. $23.1 Mn in 2024, $25.6 Mn in 2025 and $63.3 Mn in 2034, 10.6% CAGR.
Australia Insulin Resistance Supplements market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Insulin Resistance Supplements Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the insulin Resistance Supplements market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the insulin Resistance Supplements market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the insulin Resistance Supplements market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Insulin Resistance Supplements Market in Australia

The insulin Resistance Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insulin Resistance Supplements Market in Australia

Insulin Resistance Supplements in Australia: rules and research

Medicines must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Most vitamin, mineral and herbal products are listed complementary medicines, included in the Australian Register of Therapeutic Goods (ARTG) and regulated by the Therapeutic Goods Administration (TGA).⁠[1] ClinicalTrials.gov lists 1 study on Insulin Resistance Supplements that is recruiting, active or about to start in Australia.⁠[2] Diabetes (adults): 8.1% of adults in 2022, the latest WHO figure for Australia.⁠[3]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.

[3] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern insulin Resistance Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Resistance Supplements right now, from free public sources.

Clinical trials

1 active trial in Australia

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Hangzhou Sciwind Biosciences Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Signos 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Resistance Supplements in context

Australia compared

  • Diabetes (adults, WHO): 8.1% of adults (2022). World: 14.1% of adults (2022). 14th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[2]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insulin Resistance Supplements market in Australia?
Placeholder estimate: about $25.6 Mn in 2025, rising to about $63.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insulin Resistance Supplements market in Australia growing?
Placeholder estimate: about 10.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insulin Resistance Supplements market report cover?
The report splits the market by ingredient (Berberine, Inositol, Chromium, Cinnamon Extract and more), form (Capsules, Powders, Gummies) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Insulin Resistance Supplements market?
Key players include Thorne, NOW Foods, Nature’s Bounty, Pure Encapsulations, LLC and Wholesome Story.
What is driving the Insulin Resistance Supplements market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the insulin Resistance Supplements market.
Who regulates Insulin Resistance Supplements in Australia?
Medicines must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Most vitamin, mineral and herbal products are listed complementary medicines, included in the Australian Register of Therapeutic Goods (ARTG) and regulated by the Therapeutic Goods Administration (TGA). Source: Therapeutic Goods Administration. Checked 14 Nov 2026. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How many clinical trials on Insulin Resistance Supplements are running in Australia?
1 study is recruiting, active or about to start in Australia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
What does WHO report for Australia?
Diabetes (adults): 8.1% of adults in 2022, the latest WHO figure. Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.
How many people in Australia are 65 or older?
18.1% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 16 Nov 2026.
How much research is published on Insulin Resistance Supplements?
PubMed lists 2,843 papers on Insulin Resistance Supplements added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in Australia

See all

Related on diabetes and nutrition

See the topic